Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Revenue: 2014-2025

Historic Revenue for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $1.2 million.

  • AC Immune's Revenue fell 96.01% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 82.53%. This contributed to the annual value of $28.7 million for FY2025, which is N/A change from last year.
  • As of Q3 2025, AC Immune's Revenue stood at $1.2 million, which was down 25.59% from $1.6 million recorded in Q2 2025.
  • AC Immune's Revenue's 5-year high stood at $29.4 million during Q3 2024, with a 5-year trough of -$1.6 million in Q1 2022.
  • For the 3-year period, AC Immune's Revenue averaged around $3.2 million, with its median value being $399,271 (2023).
  • Over the last 5 years, AC Immune's Revenue had its largest YoY gain of 92,595.18% in 2022, and its largest YoY loss of 1,827.07% in 2022.
  • Quarterly analysis of 5 years shows AC Immune's Revenue stood at $81,338 in 2021, then surged by 401.54% to $407,943 in 2022, then decreased by 8.80% to $372,027 in 2023, then spiked by 248.88% to $1.3 million in 2024, then slumped by 96.01% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.6 million for Q2 2025, and $1.1 million during Q1 2025.